Literature DB >> 33505033

How ecstasy and psilocybin are shaking up psychiatry.

Paul Tullis.   

Abstract

Entities:  

Keywords:  Brain; Depression; Post-traumatic stress disorder; Psychiatric disorders

Mesh:

Substances:

Year:  2021        PMID: 33505033     DOI: 10.1038/d41586-021-00187-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.

Authors:  Gongliang Zhang; Herborg N Ásgeirsdóttir; Sarah J Cohen; Alcira H Munchow; Mercy P Barrera; Robert W Stackman
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

2.  Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

Authors:  F X Vollenweider; K L Leenders; C Scharfetter; P Maguire; O Stadelmann; J Angst
Journal:  Neuropsychopharmacology       Date:  1997-05       Impact factor: 7.853

3.  LSD-induced entropic brain activity predicts subsequent personality change.

Authors:  A V Lebedev; M Kaelen; M Lövdén; J Nilsson; A Feilding; D J Nutt; R L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2016-05-06       Impact factor: 5.038

Review 4.  Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.

Authors:  Franz X Vollenweider; Katrin H Preller
Journal:  Nat Rev Neurosci       Date:  2020-09-14       Impact factor: 34.870

5.  Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.

Authors:  Gabrielle I Agin-Liebes; Tara Malone; Matthew M Yalch; Sarah E Mennenga; K Linnae Ponté; Jeffrey Guss; Anthony P Bossis; Jim Grigsby; Stacy Fischer; Stephen Ross
Journal:  J Psychopharmacol       Date:  2020-01-09       Impact factor: 4.153

6.  Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Authors:  R L Carhart-Harris; M Bolstridge; C M J Day; J Rucker; R Watts; D E Erritzoe; M Kaelen; B Giribaldi; M Bloomfield; S Pilling; J A Rickard; B Forbes; A Feilding; D Taylor; H V Curran; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

7.  Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

Authors:  Alan K Davis; Frederick S Barrett; Darrick G May; Mary P Cosimano; Nathan D Sepeda; Matthew W Johnson; Patrick H Finan; Roland R Griffiths
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

  7 in total
  5 in total

1.  Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice.

Authors:  Kevin T Mintz; Brinn Gammer; Amanda J Khan; Gretchen Shaub; Steven Levine; Dominic Sisti
Journal:  Front Psychiatry       Date:  2022-05-25       Impact factor: 5.435

Review 2.  Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies.

Authors:  Johannes M Dijkstra; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2021-12-10       Impact factor: 3.850

Review 3.  Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Authors:  Paul Cumming; Milan Scheidegger; Dario Dornbierer; Mikael Palner; Boris B Quednow; Chantal Martin-Soelch
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

4.  How Psychedelic-Assisted Treatment Works in the Bayesian Brain.

Authors:  Daniel Villiger
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

5.  Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.

Authors:  Benjamin Hackl; Hannes Todt; Helmut Kubista; Karlheinz Hilber; Xaver Koenig
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.